FDA Approved: CERDELGA — Original Application (Genzyme Corporation)

View source ↗

Summary

FDA approved Cerdelga (eliglustat) from Genzyme Corporation as an oral substrate reduction therapy for adults with Gaucher disease type 1, marking the original …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Cerdelga (Eliglustat)

Snippet

ORIG AP for CERDELGA (ELIGLUSTAT)